Pain News and Research

Latest Pain News and Research

Telephone support after traffic accidents reduces problems and improves quality of life

People who were injured in road accidents had fewer problems and a much higher quality of life if they received a simple follow-up call from a nurse three weeks after being discharged from hospital, according to research in the January issue of the Journal of Clinical Nursing.

15 Jan 2009

New diagnostic tool to measure blood flow could prevent needless stents

Doctors may be implanting too many artery-opening stents and could improve patient outcomes - and ultimately save lives - if they did more in-depth measurements of blood flow in the vessels to the heart.

15 Jan 2009

Invatec launches drug-eluting balloon to treat atherosclerosis below the knee

Invatec, a comprehensive innovator of interventional products, today announced the European launch of a new peripheral balloon, the IN.PACT Amphirion paclitaxel-eluting PTA balloon catheter.

15 Jan 2009

Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer

Algeta ASA has announced that with the results of the BC1-04 study reported today it has completed its comprehensive phase II clinical program evaluating Alpharadin (radium-223) as a new treatment for bone metastases in patients with hormone-refractory prostate cancer (HRPC).

15 Jan 2009

Electrical stimulation of the brain offers hope for Parkinson's sufferers

Electrical stimulation of the brain -- a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the brain -- is riskier than drug therapy but may hold significant benefits for those with Parkinson's disease who no longer respond well to medication alone.

14 Jan 2009

Antidepressants improve symptoms of fibromyalgia

The use of antidepressant medications by patients with fibromyalgia syndrome is associated with a reduction in pain, sleep disturbances and depressed mood and improvement of health-related quality of life, according to an analysis of previous studies, which is published in the January 14, 2009 issue of JAMA.

14 Jan 2009

Treadmill exercise improves walking endurance for patients with PAD

Patients with peripheral arterial disease (PAD), which can include symptoms such as pain in the legs, who participated in supervised treadmill exercise improved their walking endurance and quality of life, according to a study in the January 14 issue of JAMA.

14 Jan 2009

Women suffer more from rheumatoid arthritis

Tuulikki Sokka from the Jyvaskyla Central Hospital, Finland, along with other members of the Quantitative Standard Monitoring of Patients with RA (QUEST-RA) program, explored possible associations between gender and disease activity measures, treatments, and clinical characteristics in more than 6,000 RA patients from 70 sites in 25 countries.

13 Jan 2009

Strong quadriceps may benefit those with knee osteoarthritis

Studies on the influence of quadriceps strength on knee osteoarthritis (OA), one of the leading causes of disability among the elderly, have shown conflicting results.

13 Jan 2009

Diabetics with previous foot ulcers may be able to participate in walking program

More than 20 million Americans are living with diabetes, and that number is expected to increase by more than 5 million by 2010.

13 Jan 2009

Epidurals and spinal anesthetics safer than previously reported

The largest ever prospective study [1,2] into the major complications [3] of epidurals and spinal anaesthetics published in the British Journal of Anaesthesia today (Monday 12 January 2009) concludes that previous studies have over-estimated the risks of severe complications of these procedures.

12 Jan 2009

Discovery of mechanism for dental pain

Researchers at Oregon Health & Science University's School of Dentistry have discovered a novel function of the peptide known as Nerve Growth Factor (NGF) in the development of the trigeminal nerve.

8 Jan 2009

Discovery of gene that increases susceptibility to Crohn's disease

Researchers at McGill University, the Research Institute of the McGill University Health Centre (RI MUHC) and the McGill University and Génome Québec Innovation Centre, along with colleagues at other Canadian and Belgian institutions, have discovered DNA variations in a gene that increases susceptibility to developing Crohn's disease.

8 Jan 2009

New genetic markers for ulcerative colitis could lead to treatment

An international consortium of researchers, including major contribution from a team led by Dr. John D. Rioux, a professor of medicine at the Université de Montréal and the Montreal Heart Institute, has identified genetic markers associated with risk for ulcerative colitis.

8 Jan 2009

New study examines the experiences of older people

It's debilitating, isolating and can lead to severe depression - yet pain is widely accepted as something to be expected and regarded as 'normal' in later life.

8 Jan 2009

Multifidus muscle design contributes to spine stability

The novel design of a deep muscle along the spinal column called the multifidus muscle may in fact be key to spinal support and a healthy back, according to researchers at the University of California, San Diego School of Medicine.

7 Jan 2009

Sun Pharmaceutical receives FDA approvals for 4 generics

Sun Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final approval from U.S. FDA for several Abbreviated New Drug Applications (ANDA).

7 Jan 2009

Strong urologic surgeons perform cutting-edge minimally invasive surgery

Urologists at the University of Rochester Medical Center (URMC) are advancing the frontiers of minimally invasive surgery as they begin to introduce single-port access (SPA) surgery to the Rochester region.

7 Jan 2009

Phase III studies of EXPAREL (DepoBupivacaine) from Pacira complete enrollment

Pacira Pharmaceuticals, Inc., an acute care specialty pharmaceutical company, announced today that enrollment has been completed in two pivotal Phase III SIMPLE trials to evaluate the safety and efficacy of a single intraoperative administration of EXPAREL(TM) (DepoBupivacaine) for prolonged postoperative analgesia.

6 Jan 2009

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).

From Baxter International Inc. 5 Jan 2009

Pain News and Research

Latest Pain News and Research

Telephone support after traffic accidents reduces problems and improves quality of life

New diagnostic tool to measure blood flow could prevent needless stents

Invatec launches drug-eluting balloon to treat atherosclerosis below the knee

Algeta completes phase II trial with Alpharadin for treating bone metastases in advanced prostate cancer

Electrical stimulation of the brain offers hope for Parkinson's sufferers

Antidepressants improve symptoms of fibromyalgia

Treadmill exercise improves walking endurance for patients with PAD

Women suffer more from rheumatoid arthritis

Strong quadriceps may benefit those with knee osteoarthritis

Diabetics with previous foot ulcers may be able to participate in walking program

Epidurals and spinal anesthetics safer than previously reported

Discovery of mechanism for dental pain

Discovery of gene that increases susceptibility to Crohn's disease

New genetic markers for ulcerative colitis could lead to treatment

New study examines the experiences of older people

Multifidus muscle design contributes to spine stability

Sun Pharmaceutical receives FDA approvals for 4 generics

Strong urologic surgeons perform cutting-edge minimally invasive surgery

Phase III studies of EXPAREL (DepoBupivacaine) from Pacira complete enrollment

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Pain News and Research

Latest Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in